icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
4 Jun, 2021 13:49

Team behind Russia’s Sputnik V says Big Pharma campaign to discredit Covid-19 jab behind low levels of vaccination in country

Team behind Russia’s Sputnik V says Big Pharma campaign to discredit Covid-19 jab behind low levels of vaccination in country

A campaign in the Western media to undermine confidence in Russia’s Sputnik V coronavirus vaccine is harming the formula’s reputation at home and abroad, the head of the investment fund that backed its development has claimed.

Kirill Dmitriev of the Russian Direct Investment Fund (RDIF), which financed the research at Moscow’s Gamaleya Institute, made the explosive allegations in an interview with RBK published on Friday. He blamed the narrative being put forward by some foreign reporters for not only tarnishing perceptions of the world’s first registered jab internationally, but also making Russians reluctant to sign up for doses.

Asked about the country’s comparatively low vaccination rate, he said that the first reason for slow uptake is “a powerful disinformation campaign that was launched against Sputnik V from the outset.” The team behind the jab, he said, “believe that those behind this are a number of Big Pharma companies, as well as anti-Russian political circles.”

Also on rt.com ‘Health is beyond politics’: WHO’s top official in Europe ‘optimistic’ about Russia’s Sputnik V vaccine emergency authorization

“From the very beginning,” he alleged, “there has been a purposeful campaign to chip away at confidence in the great achievement of our scientists, and in the effectiveness of the vaccine.” Russia made headlines last summer when it became the first nation to officially register a formula to protect against the virus.

Dmitriev added that “we see attacks on Sputnik V primarily in the Anglo-Saxon press – it is like a kind of octopus combining the tentacles of a number of Big Pharma companies and those of political players who are opposed to Russia.” This, he said, was “aimed at reducing the rate of vaccination in Russia and at raising doubts about the Russian vaccine.”

Another reason for the comparatively low rates of vaccination, the finance chief argued, was that the country has been “quite successful” in the fight against Covid-19, with the number of reported cases hovering at around a third of what they were at the peak. “As a result,” he said, “many people now, unfortunately, do not feel an urgent need to get vaccinated.”

“The approach to vaccination should be like brushing your teeth,” Dmitriev claimed. “That is to say, you can probably choose not to brush your teeth, but that isn’t accepted by society. And those people who are not vaccinated not only take big risks, but also carry them to those around and loved ones.”

Also on rt.com Some 60% of German respondents would like to get Russian-made Sputnik V coronavirus vaccine – poll

A number of Western commentators and journalists have claimed that Russia’s domestic-made vaccines are being exported as part of efforts to strengthen the country’s political sway abroad. Some have gone as far as to suggest its primary purpose is as a tool of malign influence, despite peer-reviewed evidence showing it is both safe and effectively protects against the virus.

The EU’s central regulator, the European Medicines Agency, is still conducting a months-long rolling review of the evidence behind Sputnik V. That is despite many member states expressing disquiet over the pace of the bloc’s immunization program, and two countries moving ahead by authorizing and using the jab without waiting for approval.

Sergey Naryshkin, the head of Russia’s Foreign Intelligence Service (SVR), said last month that “this procrastination is related to signals that come from on high of the European Union.” His words echoed those of President Vladimir Putin, who claimed in March that overseas interest in Sputnik V is growing, despite what he called “deliberate discrediting” and “outright fabrications.”

Think your friends would be interested? Share this story!